Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research

Abstract Background The purpose of toxicology is to protect human health and the environment. To support this, the Organisation for Economic Co-operation and Development (OECD), operating via its Extended Advisory Group for Molecular Screening and Toxicogenomics (EAGMST), has been developing the Adverse Outcome Pathway (AOP) approach to consolidate evidence for chemical toxicity spanning multiple levels of biological organization. The knowledge transcribed into AOPs provides a structured framework to transparently organize data, examine the weight of evidence of the AOP, and identify causal relationships between exposure to stressors and adverse effects of regulatory relevance. The AOP framework has undergone substantial maturation in the field of hazard characterization of chemicals over the last decade, and has also recently gained attention from the radiation community as a means to advance the mechanistic understanding of human and ecological health effects from exposure to ionizing radiation at low dose and low dose-rates. To fully exploit the value of such approaches for facilitating risk assessment and management in the field of radiation protection, solicitation of experiences and active cooperation between chemical and radiation communities are needed. As a result, the Radiation and Chemical (Rad/Chem) AOP joint topical group was formed on June 1, 2021 as part of the initiative from the High Level Group on Low Dose Research (HLG-LDR). HLG-LDR is overseen by the OECD Nuclear Energy Agency (NEA) Committee on Radiation Protection and Public Health (CRPPH). The main aims of the joint AOP topical group are to advance the use of AOPs in radiation research and foster broader implementation of AOPs into hazard and risk assessment. With global representation, it serves as a forum to discuss, identify and develop joint initiatives that support research and take on regulatory challenges. Conclusion The Rad/Chem AOP joint topical group will specifically engage, promote, and implement the use of the AOP framework to: (a) organize and evaluate mechanistic knowledge relevant to the protection of human and ecosystem health from radiation; (b) identify data gaps and research needs pertinent to expanding knowledge of low dose and low dose-rate radiation effects; and (c) demonstrate utility to support risk assessment by developing radiation-relevant case studies. It is envisioned that the Rad/Chem AOP joint topical group will actively liaise with the OECD EAGMST AOP developmental program to collectively advance areas of common interest and, specifically, provide recommendations for harmonization of the AOP framework to accommodate non-chemical stressors, such as radiation.

[1]  J. Kaiser,et al.  Expert consultation is vital for adverse outcome pathway development: a case example of cardiovascular effects of ionizing radiation , 2021, International journal of radiation biology.

[2]  K. Tollefsen,et al.  AOP Report: Inhibition of Chitin Synthase 1 Leading to Increased Mortality in Arthropods , 2021, Environmental toxicology and chemistry.

[3]  E. Perkins,et al.  Bringing together scientific disciplines for collaborative undertakings: a vision for advancing the adverse outcome pathway framework , 2021, International journal of radiation biology.

[4]  D. Villeneuve,et al.  Collaborative efforts are needed among the scientific community to advance the adverse outcome pathway concept in areas of radiation risk assessment , 2020, International journal of radiation biology.

[5]  J. Boice,et al.  Adverse outcome pathways, key events, and radiation risk assessment , 2020, International journal of radiation biology.

[6]  J. Olsen,et al.  Effects of artificial ultraviolet B radiation on the macrophyte Lemna minor: a conceptual study for toxicity pathway characterization , 2020, Planta.

[7]  Li Xie,et al.  Quantification of an Adverse Outcome Pathway Network by Bayesian Regression and Bayesian Network Modeling , 2020, Integrated environmental assessment and management.

[8]  K. Tollefsen,et al.  De novo Development of a Quantitative Adverse Outcome Pathway (qAOP) Network for Ultraviolet B (UVB) Radiation Using Targeted Laboratory Tests and Automated Data Mining. , 2020, Environmental science & technology.

[9]  R. Wilkins,et al.  Challenges in the quantification approach to a radiation relevant adverse outcome pathway for lung cancer , 2020, International journal of radiation biology.

[10]  D. Richardson,et al.  Epidemiological Studies of Low-Dose Ionizing Radiation and Cancer: Summary Bias Assessment and Meta-Analysis. , 2020, Journal of the National Cancer Institute. Monographs.

[11]  M. Blettner,et al.  Biologically based models of cancer risk in radiation research , 2020, International journal of radiation biology.

[12]  J. Kaiser,et al.  Biologically-based modeling of radiation risk and biomarker prevalence for papillary thyroid cancer in Japanese a-bomb survivors 1958–2005 , 2020, International journal of radiation biology.

[13]  Daniela Stricklin,et al.  The integration of the adverse outcome pathway framework to radiation risk assessment , 2020, International journal of radiation biology.

[14]  R. Rudel,et al.  Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast , 2020, Archives of Toxicology.

[15]  R. Rudel,et al.  Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast , 2020, Archives of Toxicology.

[16]  Alan Boobis,et al.  An evaluation framework for new approach methodologies (NAMs) for human health safety assessment. , 2020, Regulatory toxicology and pharmacology : RTP.

[17]  D. Muir,et al.  Toward a Global Understanding of Chemical Pollution: A First Comprehensive Analysis of National and Regional Chemical Inventories. , 2020, Environmental science & technology.

[18]  C. Yauk,et al.  A case example of a radiation-relevant adverse outcome pathway to lung cancer , 2019, International journal of radiation biology.

[19]  Gary S. Caldwell,et al.  Integrative assessment of low-dose gamma radiation effects on Daphnia magna reproduction: Toxicity pathway assembly and AOP development. , 2019, The Science of the total environment.

[20]  O. Lind,et al.  Modes of action and adverse effects of gamma radiation in an aquatic macrophyte Lemna minor. , 2019, The Science of the total environment.

[21]  O. Lind,et al.  Why is the multiple stressor concept of relevance to radioecology? , 2019, International journal of radiation biology.

[22]  Daniel L Villeneuve,et al.  Extracting and Benchmarking Emerging Adverse Outcome Pathway Knowledge , 2019, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  M. Blettner,et al.  Cohort Profile: the EPI-CT study: A European pooled epidemiological study to quantify the risk of radiation-induced cancer from paediatric CT. , 2018, International journal of epidemiology.

[24]  Yi Wang,et al.  Is there a role for the adverse outcome pathway framework to support radiation protection? , 2018, International journal of radiation biology.

[25]  J. Boice,et al.  Implications of recent epidemiologic studies for the linear nonthreshold model and radiation protection , 2018, Journal of radiological protection : official journal of the Society for Radiological Protection.

[26]  M. Doody,et al.  Leukaemia and myeloid malignancy among people exposed to low doses (<100 mSv) of ionising radiation during childhood: a pooled analysis of nine historical cohort studies. , 2018, The Lancet. Haematology.

[27]  B. Salbu,et al.  Gamma radiation induces dose-dependent oxidative stress and transcriptional alterations in the freshwater crustacean Daphnia magna. , 2018, The Science of the total environment.

[28]  Sharon Munn,et al.  Adverse outcome pathway networks I: Development and applications , 2018, Environmental toxicology and chemistry.

[29]  R. Leggett,et al.  The Past Informs the Future: An Overview of the Million Worker Study and the Mallinckrodt Chemical Works Cohort. , 2018, Health physics.

[30]  Stephen W. Edwards,et al.  AOP‐DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks , 2018, Toxicology and applied pharmacology.

[31]  J. Boice The linear nonthreshold (LNT) model as used in radiation protection: an NCRP update , 2017, International journal of radiation biology.

[32]  Sharon Munn,et al.  Advancing the adverse outcome pathway framework—An international horizon scanning approach , 2017, Environmental toxicology and chemistry.

[33]  Edward J. Perkins,et al.  Quantitative Adverse Outcome Pathways and Their Application to Predictive Toxicology. , 2017, Environmental science & technology.

[34]  D. Richardson,et al.  The International Nuclear Workers Study (Inworks): A Collaborative Epidemiological Study to Improve Knowledge About Health Effects of Protracted Low-Dose Exposure , 2017, Radiation protection dosimetry.

[35]  Dale L Preston,et al.  Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958–2009 , 2017, Radiation Research.

[36]  M. Tucker,et al.  Thyroid Cancer Following Childhood Low-Dose Radiation Exposure: A Pooled Analysis of Nine Cohorts , 2017, The Journal of clinical endocrinology and metabolism.

[37]  Maurice Whelan,et al.  How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory Toxicology , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  David B Richardson,et al.  Risk of cancer from occupational exposure to ionising radiation: retrospective cohort study of workers in France, the United Kingdom, and the United States (INWORKS) , 2015, BMJ : British Medical Journal.

[39]  Igor Linkov,et al.  Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence. , 2015, Regulatory toxicology and pharmacology : RTP.

[40]  Sharon Munn,et al.  Adverse outcome pathway (AOP) development I: strategies and principles. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[41]  N. Hamada,et al.  Classification of radiation effects for dose limitation purposes: history, current situation and future prospects , 2014, Journal of radiation research.

[42]  K. Tollefsen,et al.  Environmental risk assessment of combined effects in aquatic ecotoxicology: a discussion paper. , 2014, Marine environmental research.

[43]  J H Hendry,et al.  ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context , 2012, Annals of the ICRP.

[44]  Daniel L Villeneuve,et al.  Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment , 2010, Environmental toxicology and chemistry.

[45]  Icrp Preface, Executive Summary and Glossary , 2007 .

[46]  Users' Handbook supplement to the Guidance Document for developing and assessing Adverse Outcome Pathways , 2019 .

[47]  Steven K. Gibb Toxicity testing in the 21st century: a vision and a strategy. , 2008, Reproductive toxicology.

[48]  J. Valentin The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. , 2007, Annals of the ICRP.